{
    "2020-06-12": [
        [
            {
                "time": "2020-03-15",
                "original_text": "Biotech Stocks Run Up In Coronavirus Drug Race, But Here's Another Way To Buy",
                "features": {
                    "keywords": [
                        "biotech",
                        "stocks",
                        "coronavirus",
                        "drug",
                        "race"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-16",
                "original_text": "Lilly and Dermira Present New Lebrikizumab Phase 2b Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Dermira",
                        "Lebrikizumab",
                        "Phase 2b",
                        "Atopic Dermatitis",
                        "Improvements"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-17",
                "original_text": "Lilly Highlights the Evolution of Its Dermatology Portfolio at Annual American Academy of Dermatology Meeting (AAD)",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Dermatology",
                        "Portfolio",
                        "AAD"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-18",
                "original_text": "This is Why Eli Lilly (LLY) is a Great Dividend Stock",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dividend",
                        "Stock"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-19",
                "original_text": "Lilly Partners with Indianapolis Recorder Newspaper, Radio One and WISH-TV for a Day of Solidarity Virtual Event",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Partners",
                        "Indianapolis Recorder",
                        "Radio One",
                        "WISH-TV",
                        "Solidarity",
                        "Virtual Event"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "community engagement"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-20",
                "original_text": "Pharma Stock Roundup: Coronavirus Updates From ABBV, LLY, JNJ, FDA Approvals",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Coronavirus",
                        "Updates",
                        "ABBV",
                        "LLY",
                        "JNJ",
                        "FDA",
                        "Approvals"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-21",
                "original_text": "COVID-19 cases surge, officials issue warnings",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "cases",
                        "surge",
                        "officials",
                        "warnings"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-03-22",
                "original_text": "J&J exec: Our coronavirus vaccine is aiming for a 70% success rate in trials",
                "features": {
                    "keywords": [
                        "J&J",
                        "exec",
                        "coronavirus",
                        "vaccine",
                        "success",
                        "rate",
                        "trials"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}